Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment recommendations, compared to GA with usual care, works in identifying risk factors, reducing chemotherapy radiation toxicity and functional decline, and improving the overall quality of life in older patients with non-small cell lung cancer (NSCLC). Older patients with lung cancer undergoing chemotherapy are at an increased risk of adverse outcomes including treatment toxicity and functional and physical consequences. This makes it very challenging for the physicians to balance the benefits against the risk of chemotherapy in older cancer patients. A geriatric assessment may be useful in identifying risk factors for chemotherapy radiation toxicity. Communicating these geriatric assessment findings and assessment-based recommendations to a patient's treating physicians may help them make more informed decisions about treatment options for patients. Making treatment decisions using GA-based recommendations may reduce adverse events and improve outcomes in patients receiving treatment for NSCLC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma 60 lat lub więcej
- •Zdiagnozowany niezawansowany rak płuca, który nie daje się operować
- •Leczenie rozpocznie się w ciągu 4-6 tygodni od wizyty początkowej
- •Pacjent będzie otrzymywać chemioterapię lub podobne leki, być może w połączeniu z radioterapią
- •Może mieć przerzuty w jednym miejscu (np. jeden guz mózgu, jeden wierzchołek płuca)
- •Pacjent lub jego opiekun prawny mogą wyrazić świadomą zgodę na udział w badaniu
- •Lekarz zajmujący się pacjentem pracuje w ośrodku badawczym
Simplified criteria — AI translation
Trial details
- Minimum age
- 60 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (3)
City of Hope Medical Center
Duarte, United States
University of Rochester
Rochester, United States
Ohio State University Comprehensive Cancer Center
Columbus, United States
Trial contact
Arya Amini
Arya Amini
PRINCIPAL_INVESTIGATOR
Supriya G. Mohile
Supriya G. Mohile
PRINCIPAL_INVESTIGATOR
Carolyn J. Presley
Carolyn J. Presley
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.